Cannabis Use and Health among VHA Primary Care Patients
Cannabis Use and Health among VHA Primary Care Patients
批准号:
9907863
负责人:
KIPLING M BOHNERT
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-05-01 至 2021-04-30
关键词:
AddressAgeAlcohol or Other Drugs useAwarenessCannabisCertificationClinical Practice GuidelineDataDistrict of ColumbiaHealthIndividualInterventionInterviewLawsLegalLinkMedicalMedical MarijuanaMedical centerMental HealthMental disordersMethodsMichiganMilitary PersonnelMonitorNatureOpioidOutcomePainPatient CarePatientsPatternPharmaceutical PreparationsPoliciesPopulationPost-Traumatic Stress DisordersPrimary Health CareProviderQualifyingReportingResearchRural PopulationSamplingScheduleServicesSubgroupSubstance Use DisorderSuburban PopulationSymptomsTimeUnited StatesUrban PopulationVeteransVisitchronic paincohortcomparison groupfollow-uphealth administrationhealth recordillicit drug useinnovationmarijuana usemarijuana use disorderpatient populationscreeningservice memberservice utilizationsexsocial
中文摘要
背景:虽然超过100万退伍军人经常使用大麻(即,曾使用大麻,
过去一个月),只有有限的研究调查了退伍军人健康管理局中的大麻使用情况。
(VHA)患者此外,现有的健康记录不能确定使用量是否低于
大麻使用障碍,这表明经常使用大麻的相当一部分患者不是
由其VHA提供商记录或监控。考虑到以下因素之间的联系,缺乏数据令人担忧:
大麻使用和不良的身体,心理健康和社会后果。这样的后果甚至可能是
在某些人口亚群中更为明显,包括那些患有精神疾病的人,
在VHA患者人群中比例过高。尽管有潜在的危害,一些使用大麻的患者
报告说,它是有益的慢性疼痛,创伤后应激障碍(PTSD)的管理,和其他
23个州和哥伦比亚特区已经将大麻的使用合法化,
合格的医疗条件。需要进行研究,以确定和了解大麻使用的模式
以及它们与VHA初级保健患者的健康、功能和服务利用的关系。
目的:1)描述VHA初级保健患者代表性样本中大麻使用的特征; 2)
检查大麻使用与精神活性药物使用相关的程度(例如,阿片剂
和其它精神药物),物质使用,物质使用障碍症状,精神健康症状(例如,
PTSD),疼痛,功能和治疗利用率在一个横断面样本的患者,
大麻和那些没有过去一年的使用; 3)确定大麻使用和大麻使用障碍症状
初始初级保健就诊后6个月和12个月的轨迹; 4)纵向估计相关性
大麻轨迹组和精神活性药物使用之间的关系(例如,鸦片制剂和其他精神药物),
物质使用、物质使用障碍症状、精神健康症状(例如,创伤后应激障碍),疼痛,功能,
和治疗利用率。第二个目的是比较使用,轨迹,和结果之间的那些
如果没有国家颁发的医用大麻证书,
在大麻使用和问题的性质和程度方面,有证书的国家与没有证书的国家不同。
方法:为了实现这些目标,拟议的项目将筛选退伍军人接受初级保健在3
密歇根州的吸血鬼。通过筛选,该项目将确定一组500名经常使用大麻的患者
使用,定义为在过去一年中至少每月使用一次,以及年龄和性别匹配的对照组,
500名退伍军人没有使用大麻。两组都将完成一个深入的横断面基线
采访在筛选和基线后,500名经常使用大麻的患者将组成一个队列,
将在6个月和12个月随访时重新评估,以确定大麻使用和大麻使用障碍
症状轨迹和相关的健康、功能和服务利用结果。
英文摘要
Background: Although more than 1 million Veterans regularly use cannabis (i.e., have used cannabis within
the past month), only limited research has investigated cannabis use among Veterans Health Administration
(VHA) patients. Furthermore, existing health records do not ascertain use that is below the threshold of a
cannabis use disorder, suggesting that a substantial portion of patients who regularly use cannabis are not
documented or monitored by their VHA providers. This absence of data is concerning given the links between
cannabis use and adverse physical, mental health, and social outcomes. Such consequences may be even
more pronounced among certain population subgroups, including those with psychiatric illnesses, which are
overrepresented in the VHA patient population. Despite potential harms, some patients who use cannabis
report that it is beneficial for the management of chronic pain, posttraumatic stress disorder (PTSD), and other
illnesses, and 23 States and the District of Columbia have legalized the use of cannabis for individuals with
qualifying medical conditions. Research is needed to characterize and understand patterns of cannabis use
and how they relate to health, functioning, and service utilization among VHA primary care patients.
Objectives: 1) To characterize cannabis use among a representative sample of VHA primary care patients; 2)
To examine the extent to which cannabis use is associated with psychoactive medication use (e.g., opiates
and other psychotropics), substance use, substance use disorder symptoms, mental health symptoms (e.g.,
PTSD), pain, functioning, and treatment utilization among a cross-sectional sample of patients with regular
cannabis and those with no past-year use; 3) To identify cannabis use and cannabis use disorder symptom
trajectories at 6- and 12-months following an initial primary care visit; 4) To longitudinally estimate associations
between cannabis trajectory groups and psychoactive medication use (e.g., opiates and other psychotropics),
substance use, substance use disorder symptoms, mental health symptoms (e.g., PTSD), pain, functioning,
and treatment utilization. A secondary aim is to compare use, trajectories, and outcomes between those with
and without State-issued medical cannabis certification to examine how patients with medical cannabis
certification differ from those without it in the nature and extent of cannabis use and problems.
Methods: To achieve these objectives, the proposed project will screen Veterans receiving primary care at 3
VAMCs in Michigan. Through screening the project will identify a group of 500 patients with regular cannabis
use, defined as at least monthly use during the past year, and an age- and sex-matched comparison group of
500 Veterans without past-year cannabis use. Both groups will complete an in-depth cross-sectional baseline
interview. Following screening and baseline, the 500 patients with regular cannabis use will comprise a cohort
that will be re-assessed at 6- and 12-months follow-up to identify cannabis use and cannabis use disorder
symptom trajectories and related health, functioning, and service utilization outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
-
批准号:10271763
-
项目类别:
-
资助金额:$51.93万
-
财政年份:2020
-
负责人:KIPLING M BOHNERT
-
依托单位:
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
-
批准号:10627984
-
项目类别:
-
资助金额:$55.21万
-
财政年份:2020
-
负责人:KIPLING M BOHNERT
-
依托单位:
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
-
批准号:10417264
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2020
-
负责人:KIPLING M BOHNERT
-
依托单位:
Cannabis Use and Health among VHA Primary Care Patients
-
批准号:9190034
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:KIPLING M BOHNERT
-
依托单位:
VA Healthcare Delivery for OEF/OIF Veterans with Mental & Substance Use Disorders
-
批准号:10178090
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:KIPLING M BOHNERT
-
依托单位:
VA Healthcare Delivery for OEF/OIF Veterans with Mental & Substance Use Disorders
-
批准号:10179463
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:KIPLING M BOHNERT
-
依托单位:
VA Healthcare Delivery for OEF/OIF Veterans with Mental & Substance Use Disorders
-
批准号:10176566
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:KIPLING M BOHNERT
-
依托单位:
VA Healthcare Delivery for OEF/OIF Veterans with Mental & Substance Use Disorders
-
批准号:8677269
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:KIPLING M BOHNERT
-
依托单位:
VA Healthcare Delivery for OEF/OIF Veterans with Mental & Substance Use Disorders
-
批准号:9927913
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:KIPLING M BOHNERT
-
依托单位:
Epidemiology & Experimental Interventions: NIDA Research
-
批准号:7751339
-
项目类别:
-
资助金额:$3.11万
-
财政年份:2008
-
负责人:KIPLING M BOHNERT
-
依托单位:
Epidemiology & Experimental Interventions: NIDA Research
-
批准号:7559645
-
项目类别:
-
资助金额:$3.55万
-
财政年份:2008
-
负责人:KIPLING M BOHNERT
-
依托单位:
Epidemiology & Experimental Interventions: NIDA Research
-
批准号:7223022
-
项目类别:
-
资助金额:$3.45万
-
财政年份:2008
-
负责人:KIPLING M BOHNERT
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: